Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVesuvius Regulatory News (VSVS)

Share Price Information for Vesuvius (VSVS)

Share Price is delayed by 15 minutes
Get Live Data
442.40    -11.80 (-2.60%)
Bid:
442.00
Ask:
443.20
Spread: 1.20 (0.271%)
Market Cap: £1.09b
VSVS Live PriceLast checked at - London Stock Exchange

Intraday Vesuvius Share Chart

Trading Update

12 Nov 2020 07:00

RNS Number : 0528F
Vesuvius plc
12 November 2020
 

 

 

12 November 2020

 

Vesuvius plc

Trading Update

 

Vesuvius plc, a global leader in molten metal flow engineering, announces the following update covering trading in the period 1 July to 31 October 2020.

 

SAFETY RESPONSE TO COVID-19

Vesuvius' priority remains the health and safety of our employees and other stakeholders. We continue to take all necessary actions to maintain a safe working environment for our employees. All our plants have been fully operational since April and are prepared to ramp-up production as the recovery progresses.

 

TRADING SUMMARY

Demand in our end markets has improved, albeit slowly, in both our Steel and Foundry divisions during Q3 2020 and these trends have continued into Q4. On a constant currency basis, our sales in Q3 were up 7.0% quarter on quarter and although down 14.3% year on year, this is an improvement on the sales decline of 26.2% in Q2 compared to Q2 2019. The improvement in trading continued into October 2020 with sales down a more modest 7.5% compared to October 2019. 

 

COST SAVINGS

We are on track to deliver the targeted £10m per quarter of Covid-19 crisis-related savings in H2 2020 and our restructuring programmes remain on-track to deliver £19.4m per annum of recurring cost savings in 2020.

 

FINANCIAL POSITION AND LIQUIDITY

Our leverage has further reduced since H1 2020 and our available liquidity at the end of October was £448m, £73m higher than in February of this year, prior to the Covid-19 crisis impacting our financial results.

 

WORKING CAPITAL

The efficient management of working capital has been an important factor in supporting our leverage reduction and liquidity during 2020. As at the end of October, trade working capital to sales (3-month average) was 22.4%, compared to 26.7% at 30 June 2020.

 

OUTLOOK

Covid-19 infection rates continue to rise on a global basis and, therefore, significant uncertainty remains regarding the speed of recovery during 2021, despite the partial recovery in trading since Q2 2020.

 

Following a review of our results to the end of October 2020 and an updated forecast for the remainder of the year, we expect Group trading profit (EBITA(1)) in 2020 to be broadly in-line with current consensus market expectations(2).

 

Notes:

(1) Excludes separately reported items.

(2) The market consensus as at 11 November for 2020 Trading Profit (EBITA(1)) is £99.2m, based on estimates compiled by Vesuvius.

 

CONFERENCE CALL

Patrick André (Chief Executive) and Guy Young (Chief Financial Officer) will be hosting a conference call for analysts and investors at 08.30 UK time today (12 November 2020).

 

To join the call, please use the dial-in numbers below:

UK: +44 (0) 203 107 0289

US: +1 (918) 922 6506

Conference ID: 7066638

In order to join the call, participants will be required to provide the Conference ID Number listed above.

 

A replay of the call will be available approximately 2 hours after the event for two weeks on the following number:

UK: +44 (0) 203 107 0235

US: +1 (855) 859-2056

Confirmation code: 7066638

 

For further information, please contact:

 

Shareholder/analyst enquiries:

 

 

Vesuvius plc

Patrick André, Chief ExecutiveGuy Young, Chief Financial Officer

Euan Drysdale, Group Head of Corporate Finance

Pamela Antay, Head of Investor Relations

 

+44 (0) 20 7822 0000+44 (0) 20 7822 0000

+44 (0) 7584 641315

+44 (0) 7827 802277

 

 

 

Media enquiries:

 

 

MHP Communications

Andrew Jaques/ Peter Lambie

+44 (0) 203 128 8100

 

 

About Vesuvius plc

 

Vesuvius is a global leader in molten metal flow engineering and technology, serving process industries operating in challenging high-temperature conditions.

 

We develop innovative and customised solutions, often used in extremely demanding industrial environments, which enable our customers to improve their manufacturing processes, enhance product quality and reduce energy consumption. These include flow control solutions, advanced refractories and other consumable products and - increasingly - related technical services including data capture.

 

We have a worldwide presence. We serve our customers through a network of low-cost manufacturing plants located close to their own facilities, and embed our industry experts within their operations, who are all supported by our global technology centres.

 

Our core competitive strengths are our market and technology leadership, strong customer relationships, well established presence in developing markets and our global reach, all of which facilitate the expansion of our addressable markets.

 

Our ultimate goal is to create value for our customers, and to deliver sustainable, profitable growth for our shareholders giving a superior return on their investment whilst providing each of our employees with a safe workplace where he or she is recognised, developed and properly rewarded.

Forward looking statements

This announcement contains certain forward-looking statements which may include reference to one or more of the following: the Group's financial condition, results of operations, cash flows, dividends, financing plans, business strategies, operating efficiencies or synergies, budgets, capital and other expenditures, competitive positions, growth opportunities for existing products, plans and objectives of management and other matters.

 

Statements in this announcement that are not historical facts are hereby identified as "forward-looking statements". Such forward looking statements, including, without limitation, those relating to the future business prospects, revenue, working capital, liquidity, capital needs, interest costs and income, in each case relating to Vesuvius, wherever they occur in this announcement, are necessarily based on assumptions reflecting the views of Vesuvius and involve a number of known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by the forward looking statements. Such forward looking statements should, therefore, be considered in light of various important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements. These include without limitation: economic and business cycles; the terms and conditions of Vesuvius' financing arrangements; foreign currency rate fluctuations; competition in Vesuvius' principal markets; acquisitions or disposals of businesses or assets; and trends in Vesuvius' principal industries.

 

The foregoing list of important factors is not exhaustive. When considering forward looking statements, careful consideration should be given to the foregoing factors and other uncertainties and events, as well as factors described in documents the Company files with the UK regulator from time to time including its annual reports and accounts.

 

You should not place undue reliance on such forward-looking statements which speak only as of the date on which they are made. Except as required by the Rules of the UK Listing Authority and the London Stock Exchange and applicable law, Vesuvius undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this announcement might not occur.

 

Vesuvius plc, 165 Fleet Street, London EC4A 2AE

Registered in England and Wales No. 8217766

LEI: 213800ORZ521W585SY02

www.vesuvius.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGBDBGSBDGGB
Date   Source Headline
11th Dec 202010:57 amRNSDirector/PDMR Shareholding
4th Dec 202010:14 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSDirectorate Change
24th Nov 20203:07 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSTrading Update
22nd Oct 20209:50 amRNSHolding(s) in Company
20th Oct 20207:00 amRNSDividend Declaration
13th Oct 202011:30 amRNSTotal Voting Rights
6th Oct 202010:42 amRNSHolding(s) in Company
17th Sep 20207:00 amRNSDebt and Liquidity Update
2nd Sep 20208:31 amRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSResults for the six months ended 30 June 2020
13th May 202012:44 pmRNSResult of AGM 2020
13th May 20207:00 amRNSAGM Trading Update
30th Apr 202011:28 amRNSChange in Director's Details
27th Apr 20206:13 pmRNSHolding(s) in Company
24th Apr 20205:13 pmRNSHolding(s) in Company
14th Apr 20205:37 pmRNSAnnual Financial Report 31 December 2019
9th Apr 20202:15 pmRNSTotal Voting Rights
6th Apr 20203:30 pmRNSStatement on COVID-19
2nd Apr 20209:45 amRNSHolding(s) in Company
24th Mar 20208:24 amRNSHolding(s) in Company
23rd Mar 20204:03 pmRNSDirector/PDMR Shareholding
13th Mar 202012:52 pmRNSDirector/PDMR Shareholding
13th Mar 202012:52 pmRNSDirector/PDMR Shareholding
11th Mar 202010:48 amRNSDirector/PDMR Shareholding
5th Mar 20204:45 pmRNSHolding(s) in Company
3rd Mar 20205:07 pmRNSHolding(s) in Company
27th Feb 20207:00 amRNSResults for the year ended 31 December 2019
20th Feb 20203:14 pmRNSHolding(s) in Company
3rd Feb 202011:53 amRNSChange in Director's Details
4th Dec 20194:24 pmRNSNon-executive Director Changes
15th Oct 20197:00 amRNSQ3 2019 Trading Update
2nd Oct 20195:36 pmRNSHolding(s) in Company
26th Sep 20196:00 pmRNSDirector/PDMR Shareholding
3rd Sep 201912:33 pmRNSTotal Voting Rights
26th Jul 201912:18 pmRNSHolding(s) in Company
25th Jul 20197:00 amRNSHalf-year Report
5th Jun 20191:20 pmRNSDirector/PDMR Shareholding
21st May 20194:03 pmRNSChange in Director's Details
15th May 20192:30 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement
23rd Apr 20195:28 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:21 pmRNSAnnual Financial Report
19th Mar 20194:35 pmRNSTotal Voting Rights
15th Mar 20193:45 pmRNSDirector/PDMR Shareholding
15th Mar 20193:45 pmRNSDirector/PDMR Shareholding
4th Mar 20194:30 pmRNSHolding(s) in Company
1st Mar 20194:42 pmRNSCompletion of the acquisition of CCPI Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.